Adebrelimab and a TKI in Combination With GEMOX in First-line Treatment of Advanced Biliary Tract Cancers (BTC)

Clinical trial NCT06320301 · UNKNOWN

Trial details

NCT number: NCT06320301
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer Gemox Chemotherapy

Start date: 2024-04-01
Primary completion: 2026-02-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.